secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2022-05-27T23:59:59+00:00
Accession:  0001438133-22-000106
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tandem Diabetes shareholders elect directors, approve board declassification and say-on-pay
--------------------------------------------------------------------------------

- Peyton R. Howell and John F. Sheridan elected as Class III directors with ~98.6% and ~98.1% of votes cast.
- Amendment to declassify board (annual elections) approved with 99.9% of votes cast in favor.
- Non-binding advisory vote on named executive officer compensation approved with ~98.4% of votes cast.
- Ratification of Ernst & Young as independent auditor for FY2022 approved with ~97.7% of votes cast.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813322000106/0001438133-22-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813322000106/tndm-20220525.htm
  HTML page:      https://secwatch.observer/filing/0001438133-22-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer